Henry Houlden

64.7k total citations · 5 hit papers
512 papers, 20.7k citations indexed

About

Henry Houlden is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, Henry Houlden has authored 512 papers receiving a total of 20.7k indexed citations (citations by other indexed papers that have themselves been cited), including 247 papers in Molecular Biology, 205 papers in Cellular and Molecular Neuroscience and 173 papers in Neurology. Recurrent topics in Henry Houlden's work include Genetic Neurodegenerative Diseases (117 papers), Neurological diseases and metabolism (102 papers) and Hereditary Neurological Disorders (101 papers). Henry Houlden is often cited by papers focused on Genetic Neurodegenerative Diseases (117 papers), Neurological diseases and metabolism (102 papers) and Hereditary Neurological Disorders (101 papers). Henry Houlden collaborates with scholars based in United Kingdom, United States and Italy. Henry Houlden's co-authors include John Hardy, Mary M. Reilly, Andrew Singleton, Michael Mullan, Fiona Crawford, Nicholas Wood, Janice L. Holton, Kailash P. Bhatia, Tamás Révész and Andrew J. Lees and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Henry Houlden

479 papers receiving 20.2k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N–terminus of β–amyloid

1992 1.1k citations Henry Houlden et al. profile →
Early-onset Alzheimer's disease caused by mutations at codon 717 of the β-amyloid precursor protein gene

1991 913 citations Henry Houlden, Liana Fidani et al. profile →
Association of an Extended Haplotype in the Tau Gene with Progressive Supranuclear Palsy

1999 600 citations Mary V. Baker, Henry Houlden et al. profile →
A common polymorphism in the brain‐derived neurotrophic factor gene ( BDNF ) modulates human cortical plasticity and the response to rTMS

2008 539 citations Mark J. Edwards, Henry Houlden et al. profile →
Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease

2009 509 citations Reema Paudel, Andrew Singleton et al. Brain profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Henry Houlden United Kingdom	70	8.9k	7.0k	7.0k	6.7k	5.1k	512	20.7k
Gen Sobue Japan	82	12.4k 1.4×	9.6k 1.4×	11.6k 1.7×	4.2k 0.6×	2.9k 0.6×	754	28.1k
Yoshikuni Mizuno Japan	78	10.1k 1.1×	9.7k 1.4×	14.8k 2.1×	4.5k 0.7×	4.8k 0.9×	403	26.7k
Shoji Tsuji Japan	65	8.8k 1.0×	6.7k 0.9×	6.7k 1.0×	3.3k 0.5×	2.3k 0.4×	507	17.1k
Lee J. Martin United States	76	9.0k 1.0×	8.7k 1.2×	5.3k 0.8×	4.3k 0.6×	3.2k 0.6×	242	21.6k
Thomas Klockgether Germany	80	8.8k 1.0×	10.2k 1.4×	10.7k 1.5×	3.8k 0.6×	4.1k 0.8×	386	23.9k
Alexis Brice France	88	16.9k 1.9×	18.9k 2.7×	16.2k 2.3×	6.1k 0.9×	6.7k 1.3×	548	35.8k
Thomas D. Bird United States	62	7.5k 0.8×	3.4k 0.5×	3.7k 0.5×	10.4k 1.5×	3.5k 0.7×	201	17.3k
Zbigniew K. Wszołek United States	73	4.6k 0.5×	5.3k 0.7×	12.5k 1.8×	5.6k 0.8×	5.0k 1.0×	461	18.9k
Matthew J. Farrer United States	77	6.2k 0.7×	9.1k 1.3×	16.9k 2.4×	5.5k 0.8×	5.5k 1.1×	330	22.2k
Eleonora Aronica Netherlands	90	9.9k 1.1×	9.3k 1.3×	3.1k 0.4×	4.1k 0.6×	4.7k 0.9×	503	27.1k

Countries citing papers authored by Henry Houlden

Since Specialization

Citations

This map shows the geographic impact of Henry Houlden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henry Houlden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henry Houlden more than expected).

Fields of papers citing papers by Henry Houlden

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Henry Houlden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henry Houlden. The network helps show where Henry Houlden may publish in the future.

Co-authorship network of co-authors of Henry Houlden

This figure shows the co-authorship network connecting the top 25 collaborators of Henry Houlden. A scholar is included among the top collaborators of Henry Houlden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Henry Houlden. Henry Houlden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pellerin, David, Pablo Iruzubieta, Matt C. Danzi, et al.. (2025). Recent Advances in the Genetics of Ataxias: An Update on Novel Autosomal Dominant Repeat Expansions. Current Neurology and Neuroscience Reports. 25(1). 16–16. 5 indexed citations

Zhang, Kejia, Jenna M. Lentini, Jonathan C. Howard, et al.. (2025). Human TRMT1 and TRMT1L paralogs ensure the proper modification state, stability, and function of tRNAs. Cell Reports. 44(1). 115092–115092. 5 indexed citations

Türkdoğan, Dilşad, et al.. (2024). The First Case of Autosomal Recessive Cerebellar Ataxia with Prominent Paroxysmal Non‐kinesigenic Dyskinesia Caused by a Truncating FGF14 Variant in a Turkish Patient. Movement Disorders. 40(2). 370–375.

Ahmad, Riaz, et al.. (2024). Report of a novel missense TDP1 variant in a Pakistani family affected with an extremely rare disorder congenital spinocerebellar ataxia with axonal neuropathy type 1 (SCAN1). Molecular Biology Reports. 52(1). 7–7. 2 indexed citations

Rahman, Fatima, Abolfazl Rad, Gabriela Oprea, et al.. (2024). Bi-allelic MYMX variants cause a syndromic congenital myopathy with recognizable facial palsy, growth restriction, and dysmorphism. European Journal of Human Genetics. 33(4). 552–555.

Koutsis, Georgios, David Pellerin, Pablo Iruzubieta, et al.. (2024). Screening for SCA27B, CANVAS and other repeat expansion disorders in Greek patients with late-onset cerebellar ataxia suggests a need to update current diagnostic algorithms. Journal of the Neurological Sciences. 467. 123309–123309. 2 indexed citations

Sultan, Tipu, et al.. (2023). Clinical and molecular heterogeneity of VPS13D-related neurodevelopmental and movement disorders. Gene. 899. 148119–148119. 4 indexed citations

Schwarz, Ghil, Gargi Banerjee, Isabel C. Hostettler, et al.. (2022). MRI and CT imaging biomarkers of cerebral amyloid angiopathy in lobar intracerebral hemorrhage. International Journal of Stroke. 18(1). 85–94. 16 indexed citations

Cheng, Fubo, Chang Liu, Peter A. Barbuti, et al.. (2022). Intronic enhancers of the human SNCA gene predominantly regulate its expression in brain in vivo. Science Advances. 8(47). eabq6324–eabq6324. 6 indexed citations

10.

Rocca, Clarissa, et al.. (2022). Epileptic Phenotypes Associated With SNAREs and Related Synaptic Vesicle Exocytosis Machinery. Frontiers in Neurology. 12. 806506–806506. 17 indexed citations

11.

Efthymiou, Stéphanie, Vykuntaraju K. Gowda, Perumal Varalakshmi, et al.. (2021). Novel ALDH3A2 mutations in structural and functional domains of FALDH causing diverse clinical phenotypes in Sjögren–Larsson syndrome patients. Human Mutation. 42(8). 1015–1029. 3 indexed citations

12.

Xiromerisiou, Georgia, Thomas Bourinaris, Henry Houlden, et al.. (2021). SORL1 mutation in a Greek family with Parkinson's disease and dementia. Annals of Clinical and Translational Neurology. 8(10). 1961–1969. 4 indexed citations

13.

Scriba, Carolin K., Sarah J. Beecroft, Joshua S. Clayton, et al.. (2020). A novel RFC1 repeat motif (ACAGG) in two Asia-Pacific CANVAS families. Brain. 143(10). 2904–2910. 53 indexed citations

14.

Efthymiou, Stéphanie, et al.. (2019). A de novo truncating mutation in ASXL1 associated with segmental overgrowth. UCL Discovery (University College London). 2 indexed citations

15.

Piard, Juliette, George K. E. Umanah, Frederike L. Harms, et al.. (2017). A homozygous ATAD1 mutation impairs postsynaptic AMPA receptor trafficking and causes a lethal encephalopathy. Brain. 141(3). 651–661. 35 indexed citations

16.

Sly, Laura M., Joshua Hersheson, Alejandro Horga, et al.. (2014). Extended phenotypic spectrum of KIF5A mutations. UCL Discovery (University College London). 3 indexed citations

17.

Moss, Davina J. Hensman, Mark Poulter, Jon Beck, et al.. (2013). C9orf72 expansions are the most common genetic cause of Huntington disease phenocopies. Neurology. 82(4). 292–299. 137 indexed citations

18.

Houlden, Henry, Susanne A. Schneider, Reema Paudel, et al.. (2010). THAP1 mutations (DYT6) are an additional cause of early-onset dystonia. Neurology. 74(10). 846–850. 68 indexed citations

19.

Carvalho, Ofélia P., Jozef Hertecant, Henry Houlden, et al.. (2010). A novel NGF mutation clarifies the molecular mechanism and extends the phenotypic spectrum of the HSAN5 neuropathy. Journal of Medical Genetics. 48(2). 131–135. 66 indexed citations

20.

Houlden, Henry, et al.. (2000). Pathologically confirmed corticobasal degeneration shares the same tau haplotype association as progressive supranuclear palsy. UCL Discovery (University College London). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact